Search research articles
Contact Us
Filters
Showing results (101-110 of 141) with videos related to
Page
of 15
Sort By:
Neurology
|
November 1, 1979
Plasma concentrations of phensuximide, methsuximide, and their metabolites in relation to clinical efficacy
R J Porter, J K Penry, J R Lacy, et al.
British Journal of Clinical Pharmacology
|
August 1, 1982
Phenytoin: an inhibitor and inducer of primidone metabolism in an epileptic patient
M G Porro, H J Kupferberg, R J Porter, et al.
Archives of Neurology
|
August 1, 1983
Clinical and EEG estimates of absence seizure frequency
T R Browne, F E Dreifuss, J K Penry, et al.
Clinical Pharmacology and Therapeutics
|
April 1, 1981
Mechanism of valproate-phenobarbital interaction in epileptic patients
I M Kapetanović, H J Kupferberg, R J Porter, et al.
Neurology
|
August 1, 1994
The secondarily generalized tonic-clonic seizure: a videotape analysis
W H Theodore, R J Porter, P Albert, et al.
Journal of Psychopharmacology (Oxford, England)
|
May 23, 2009
Effects of acute tryptophan depletion on neuropsychological and motor function in Parkinson's disease
J L Mace, R J Porter, J C Dalrymple-Alford, et al.
Annals of Neurology
|
January 1, 1984
The role of positron emission tomography in the evaluation of seizure disorders
W H Theodore, R Brooks, S Sato, et al.
Epilepsia
|
January 1, 1991
Effect of felbamate on plasma levels of carbamazepine and its metabolites
F Albani, W H Theodore, P Washington, et al.
Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism
|
June 1, 1986
Effect of phenytoin on human cerebral glucose metabolism
W H Theodore, D Bairamian, M E Newmark, et al.
Annals of Neurology
|
July 1, 1985
The clinical value of free phenytoin levels
W H Theodore, L Yu, B Price, et al.
Page
of 15
Search research articles
Search
Showing results (101-110 of 141) with videos related to
Sort By:
Page
of 15
Neurology
|
November 1, 1979
Plasma concentrations of phensuximide, methsuximide, and their metabolites in relation to clinical efficacy
R J Porter, J K Penry, J R Lacy, et al.
British Journal of Clinical Pharmacology
|
August 1, 1982
Phenytoin: an inhibitor and inducer of primidone metabolism in an epileptic patient
M G Porro, H J Kupferberg, R J Porter, et al.
Archives of Neurology
|
August 1, 1983
Clinical and EEG estimates of absence seizure frequency
T R Browne, F E Dreifuss, J K Penry, et al.
Clinical Pharmacology and Therapeutics
|
April 1, 1981
Mechanism of valproate-phenobarbital interaction in epileptic patients
I M Kapetanović, H J Kupferberg, R J Porter, et al.
Neurology
|
August 1, 1994
The secondarily generalized tonic-clonic seizure: a videotape analysis
W H Theodore, R J Porter, P Albert, et al.
Journal of Psychopharmacology (Oxford, England)
|
May 23, 2009
Effects of acute tryptophan depletion on neuropsychological and motor function in Parkinson's disease
J L Mace, R J Porter, J C Dalrymple-Alford, et al.
Annals of Neurology
|
January 1, 1984
The role of positron emission tomography in the evaluation of seizure disorders
W H Theodore, R Brooks, S Sato, et al.
Epilepsia
|
January 1, 1991
Effect of felbamate on plasma levels of carbamazepine and its metabolites
F Albani, W H Theodore, P Washington, et al.
Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism
|
June 1, 1986
Effect of phenytoin on human cerebral glucose metabolism
W H Theodore, D Bairamian, M E Newmark, et al.
Annals of Neurology
|
July 1, 1985
The clinical value of free phenytoin levels
W H Theodore, L Yu, B Price, et al.
Page
of 15